The goal of this study is to find the highest dose of α-TEA that can be given to patients
safely, to identify potential side effects of α-TEA, and to measure the amount of α-TEA in
patients' blood.
Additional goals of this study are to monitor the effect on tumors, to check for specific
immune cells circulating in the blood, and to see if there are certain features of tumors
that make it possible to predict the response to α-TEA.